TrialEuropean urology2020

The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis.

Michael Cullen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.